{
    "title": "Pfizer's COVID drug data supports use in high-risk patients - FDA staff (March 14)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11858535/Pfizers-COVID-drug-data-supports-use-high-risk-patients--FDA-staff.html",
    "date": "2023-03-14",
    "keywords": [
        "drug",
        "approval",
        "pfizer",
        "risk",
        "rebound",
        "khushi",
        "mandowara",
        "use",
        "disease",
        "pill",
        "director",
        "evidence",
        "covid",
        "leroy",
        "march",
        "health",
        "staff",
        "tuesday",
        "food",
        "administration",
        "assessment",
        "meeting",
        "thursday",
        "covid19",
        "fdas",
        "agency",
        "advice",
        "expert",
        "emergency",
        "advertising",
        "campaign",
        "treatment",
        "president",
        "joe",
        "biden",
        "dr",
        "anthony",
        "institute",
        "allergy",
        "year",
        "stage",
        "rate",
        "placebo",
        "regardless",
        "omicron",
        "variant",
        "scott",
        "drydenpeterson",
        "outpatient",
        "mass",
        "brigham",
        "boston",
        "data",
        "uptake",
        "flexibility",
        "paxlovid",
        "reduction",
        "hospitalization",
        "death",
        "highrisk",
        "adult",
        "study",
        "leo",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}